Wisp, a women’s telehealth company, announced last week that it has launched a diagnostics arm, offering at-home test kits for several health conditions.

New York City-based Wisp is a direct-to-consumer company offering treatments for different sexual and reproductive health needs, including birth control, sexually transmitted diseases and hormonal health.

To start, the diagnostics arm will offer testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium. Wisp members provide swab and urine samples and send them to a CLIA/CAP accredited lab with a prepaid label. They then receive results in three to five business days. Based on the test results, the company can provide follow-up care as well. The tests cost between $99 and $149.

“We launched at-home testing to close

See Full Page